Healthcare & Life Sciences
Industry knowledge and substantial experience in healthcare & life sciences
Strategic advice for public & private organisations
Our clients come to us because we have one of the most integrated and comprehensive life sciences practices in the CEE/SEE region, offering legal advice to the largest and most innovative life sciences companies.
In addition to our specialised expertise in different legal areas of the life sciences industry, our lawyers also understand the economic, regulatory, market and political climates your business faces across the region.
You can rely on our firm’s long-standing experience and our knowledge of local and regional government agencies. This means that whether you are a public or a private life science company, we can provide a full range of legal services at every stage of your development; from start-up and emerging growth companies to mature international and public companies.
Key Contacts
We can advise you in connection with:
- Advertising and Promotions
- Big Data, Internet of Things and Artificial Intelligence
- Competition and Antitrust
- Compliance and Corporate Investigations
- Consumer Actions and Tort Cases
- Cooperation Contracts with Life Sciences Professionals and Institutions
- Corporate restructurings, financing, M&A
- Data Protection and Data Privacy
- Digital Health and Telemedicine
- Distribution and Agency Agreements, parallel Imports
- Drug Admission & Labelling
- Employment Issues
- Foods and Food Additives
- Intellectual Property – Patents, Trademarks and Know-how, and IP litigation
- Medical Devices
- Pharmaceuticals and Biotech
- PPPs
- Pricing and Reimbursement
- Product Liability
- Product Life Cycle
- Professional Liability
- Public Procurement
- R&D Contracts
- Regulatory Issues
- Technology Transfers, Licensing and Outsourcing
What others say about us
“The firm is recognised by clients for its work ethos, one saying: ‘I value the reliability in terms of keeping deadlines,’ and its ‘flexibility in offering customised solutions.’”
– Chambers Europe
“Another client states: ‘They provide us with very good detailed legal advice and insights into […] healthcare law and adjacent areas.’”
– Chambers Europe
Get in touch
When you need an international team with extensive experience, Wolf Theiss is your right partner to support your business goals through profound legal practice.
Related insights
Life Sciences Bulletin: Phase I clinical trials open to Serbian private healthcare
On 3 December, the Serbian Ministry of Health adopted the Amendments to the Rulebook on Clinical Trials of Human Medicine,...
Read moreLife Sciences Bulletin: New public foundation to oversee exceptional drug funding in Hungary as of 2025
Commencing in 2025, the Batthyány-Strattmann László Foundation will assume the responsibility of managing applications ...
Read moreNavigating scarcity: solutions for medicine shortages in the EU, Central and Eastern Europe
Medicine shortages have become a troubling issue across the world, and Europe is no exception. A number of factors contrib...
Read moreLife Sciences Bulletin: CJEU ruling on the online sale of OTC medicines may impact Hungarian market
The recent judgement of the Court of Justice of the European Union (“CJEU”) on the sale of over-the-counter (O...
Read moreHungarian legislation reform related to centralised procurement for institutional pharmacies
The governmental decree published on 22 February (No. 33/2024 (II. 22.)) sets forth the establishment of a new project com...
Read moreUkraine takes ground-breaking step by legalising medical cannabis to enhance patient care
The President of Ukraine has officially signed Law No. 3528-IX “On Amendments to Certain Laws of Ukraine Regarding t...
Read moreLife Sciences Bulletin: Recent notable changes to life sciences regulation in Hungary
A reorganisation of the authorities regulating the pharma sector and new legislative pieces havebrought notable changes to...
Read moreLife Science Bulletin: Upcoming changes to parallel distribution of medicinal products in Bulgaria
In August 2023, the Bulgarian Ministry of Health published a draft bill for amendment of the Law on Medicinal Products in ...
Read moreWolf Theiss advises Dr.Max Group on the acquisition of Gedeon Richter’s operations in Romania
Bucharest, 21 October 2022 – Dr.Max Group, owned by Penta Investments, relied on the legal expertise of Wolf Theiss for ...
Read moreWolf Theiss advises the shareholders of Dacia Plant on the sale of a majority stake to Ceres Pharma
Bucharest, 4 October 2022 – The shareholders of Dacia Plant relied on the legal advice of Wolf Theiss regarding the ...
Read moreEuropean Health Data Space: the future of health data access and sharing in the EU
By Ira Peric Ostojic and Sara Pavlovic The Covid-19 pandemic has highlighted the need to have timely access to and sharing...
Read moreWolf Theiss expands in Slovakia: Bruno Štefánik and Marko Ernek join Bratislava office
Bratislava, 22 June 2020 – Bruno Štefánik and Marko Ernek will join the Bratislava office of Wolf Theiss as Counsel an...
Read more